12 June 2024
Directa Plus plc
Posting of Circular and Notice of General Meeting
Directa Plus (AIM: DCTA) (the "Company"), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, confirms that, further to the announcements of 11 June 2024, copies of the Circular (incorporating the Notice of General Meeting) together with electronic voting information, have been sent to eligible Shareholders.
The Circular and Notice of General Meeting will shortly be available on the Company's website at www.directa-plus.com.
The General Meeting to approve the Resolutions is expected to be held at the offices of Vistra, 7th Floor, 50 Broadway,
The expected timetable set out in the initial announcement of 11 June 2024 remains unchanged.
Capitalised terms not otherwise defined in the text of this Announcement have the meanings given in the Company's announcement regarding the proposed Fundraising released at 7.00 a.m. on 11 June 2024.
For further information, please contact:
Directa Plus plc |
+39 02 36714458 |
Giulio Cesareo, CEO |
|
Giorgio Bonfanti, CFO |
|
|
|
Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker) |
+44 131 220 6939 |
Neil McDonald |
|
Adam Rae |
|
|
|
Singer Capital Markets Securities Limited (Joint Broker) |
+44 20 7496 3069 |
Rick Thompson |
|
Phil Davies |
|
|
|
Alma Strategic Communications (Financial PR Adviser) |
+44 20 3405 0205 |
Justine James |
|
Hannah Campbell |
|
Kinvara Verdon |
|
Notes to Editors
Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and paste.
This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, nontoxic product, without unwanted by-products.
Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+(R)) have multiple applications due to its properties. These G+(R) products can be categorised into various families, with different products being suitable for specific practical applications.
Directa Plus was established in 2005 and is based in Lomazzo (
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.